Cerebellar ataxias

Current Opinion in Neurology

Volumn 22, Issue 4, 2009, Pages 419-429

  Manto, Mario ^a   Marmolino, Daniele ^a  

^a FNRS   (Belgium)

Author keywords

Ataxias; Cerebellum; Dominant; Dysmetria; Recessive; X linked

Indexed keywords

4 AMINOPYRIDINE; 5 HYDROXYTRYPTOPHAN; ACETAZOLAMIDE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA TOCOPHEROL; AMANTADINE; ANTICONVULSIVE AGENT; BACLOFEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; BUSPIRONE; CHENODEOXYCHOLIC ACID; CYCLOSPORIN; DEFEROXAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; IDEBENONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LAMOTRIGINE; LEVODOPA; LITHIUM SALT; METRONIDAZOLE; MEXILETINE; PRAVASTATIN; QUININE; RECOMBINANT ERYTHROPOIETIN; SPASMOLYTIC AGENT; TANDOSPIRONE; UBIDECARENONE; UNINDEXED DRUG;

ALGORITHM; ATAXIA; AUTOSOMAL DOMINANT CEREBELLAR ATAXIA; AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA; BRAIN DEPTH STIMULATION; CEREBELLAR ATAXIA; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MEGADOSE; DYSTONIA; EPISODIC ATAXIA; FRIEDREICH ATAXIA; GLUTEN FREE DIET; HUMAN; MUSCLE CRAMP; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; REVIEW; SPASTICITY; SPINOCEREBELLAR ATAXIA; URINARY URGENCY; VITAMIN SUPPLEMENTATION; X LINKED ATAXIA;

CEREBELLAR ATAXIA; CEREBELLUM; HUMANS; MUTATION;

EID: 68449099404     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32832b9897     Document Type: Review

References (44)

1. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71:670-676.
2. Hadjivassiliou M, Sanders DS, Woodroofe N, et al. Gluten ataxia. Cerebellum 2008; 7:494-498.
3. Palau F, Espinos C. Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis 2006; 1:47.
4. Marmolino D, Acquaviva F. Friedreich's ataxia: from the (GAA)(n) repeat mediated silencing to new promising molecules for therapy. Cerebellum 2009 [Epub ahead of print].
5. Herman D, Jenssen K, Burnett R, et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol 2006; 2:551-558.
6. Montero R, Pineda M, Aracil A, et al. Clinical, biochemical and molecular aspects of cerebellar ataxia and Coenzyme Q10 deficiency. Cerebellum 2007; 6:118-122.
7. Mollet J, Giurgea I, Schlemmer D, et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 2007; 117:765-772.
8. Crawford TO. Ataxia telangiectasia. Semin Pediatr Neurol 1998; 5:287-294.
9. Smirnov DA, Cheung VG. ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs. Am J Hum Genet 2008; 83:243-253.
10. Le Ber I, Bouslam N, Rivaud-Péchoux S, et al. Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain 2004; 127:759-767.
11. Montalvo ALE, Filocamo M, Vlahovicek K, et al. Molecular analysis of the HEXA gene in Italian patients with infantile and late onset Tay-Sachs disease: detection of fourteen novel alleles. Hum Mutat 2005; 26:2-8.
12. Verrips A, Hoefsloot LH, Steenbergen GCH, et al. Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 2000; 123:908-919.
13. Szlago M, Gallus GN, Schenone A, et al. The first cerebrotendinous xanthomatosis family from Argentina: a new mutation in CYP27A1 gene. Neurology 2008; 70:402-404.
14. Jansen GA, Waterham HR, Wanders RJA. Molecular basis of Refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7). Hum Mutat 2004; 23:209-218.
15. El-Khamisy SF, Saifi GM, Weinfeld M, et al. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 2005; 434:108-113.
16. El-Khamisy SF, Caldecott KW. TDP1-dependant DNA single-strand break repair and neurodegeneration. Mutagenesis 2006; 21:219-224.
17. Breckpot J, Takiyama Y, Thienpont B, et al. A novel genomic disorder: a deletion of the SACS gene leading to spastic ataxia of Charlevoix-Saguenay. Eur J Hum Genet 2008; 16:1050-1054.
18. Vermeer S, Meijer RPP, Pijl BJ, et al. ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia. Neurogenetics 2008; 9:207-214.
19. Nikali K, Suomalainen A, Saharinen J, et al. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins twinkle and twinky. Hum Mol Genet 2005; 14:2981-2990.
20. Buschdorf JP, Chew LL, Zhang B, et al. Brain-specific BNIP-2-homology protein Caytaxin relocalizes glutaminase to neurite terminals and reduces glutamate levels. J Cell Sci 2006; 119:3337-3350.
21. Anttonen AK, Siintola E, Tranebjaerg L, et al. Novel SIL1 mutations and exclusion of functional candidate genes in Marinesco-Sjogren syndrome. Eur J Hum Genet 2008; 16:961-969. Anttonen et al. report four novel mutations in SIL1, including the first missense substitution p. Leu457Pro described in MSS. In addition, they excluded three functional candidate genes, HSPA5, HYOU1, and AARS, as causative genes in SIL1 mutation-negative patients.
22. Senderek J, Krieger M, Stendel C, et al. Mutations in SIL1 cause Marinesco-Sjogren syndrome, a cerebellar ataxia with cataract and myopathy. Nat Genet 2005; 37:1312-1314.
23. Tsuji S, Onodera O, Goto J, Nishizawa M, Study Group on Ataxic Diseases. Sporadic ataxias in Japan: a population-based epidemiological study. Cerebellum 2008; 7:189-197.
24. Klockgether T. Ataxias. Parkinsonism Relat Disord 2007; 13:S391-S394.
25. Döhlinger S, Hauser TK, Borkert J, et al. Magnetic resonance imaging in spinocerebellar ataxias. Cerebellum 2008; 7:204-214.
26. Lasek K, Lencer R, Gaser C, et al. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain 2006; 129: 2341-2352.
27. Jen JC. Hereditary episodic ataxias. Ann N Y Acad Sci 2008; 1142:250-253.
28. Chen H, von Hehn C, Kaczmarek LK, et al. Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia. Neurogenetics 2007; 8:131-135.
29. Riant F, Mourtada R, Saugier-Veber P, Tournier-Lasserve E. Large CACNA1A deletion in a family with episodic ataxia type 2. Arch Neurol 2008; 65:817-820.
30. Kerber KA, Jen JC, Lee H, et al. A new episodic ataxia syndrome with linkage to chromosome 19q13. Arch Neurol 2007; 64:749-752.
31. Adams JS, Adams PE, Nguyen D, et al. Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology 2007; 69:851-859.
32. Berry-Kravis E, Abrams L, Coffey SM, et al. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord 2007; 22:2018-2030.
33. Zeviani M. The expanding spectrum of nuclear gene mutations in mitochondrial disorders. Semin Cell Dev Biol 2001; 12:407-416.
34. Brusse E, Maat-Kievit JA, van Swieten JC. Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet 2007; 71:12-24.
35. Tzoulis C, Engelsen BA, Telstad W, et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 2006; 129:1685-1692.
36. Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous immunoglobulin therapy for Miller-Fisher syndrome. Neurology 2007; 68:1144-1146.
37. Tonon C, Lodi R. Idebenone in Friedreich's ataxia. Expert Opin Pharmacother 2008; 9:2327-2337.
38. Acquaviva F, Castaldo I, Filla A, et al. Recombinant human erythropoietin increases frataxin protein expression without increasing mRNA expression. Cerebellum 2008; 7:360-365.
39. Underwood BR, Rubinsztein DC. Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies. Cerebellum 2008; 7:215-221.
40. Ramnani N. The primate cortico-cerebellar system: anatomy and function. Nat Rev Neurosci 2006; 7:511-522.
41. Manto M, Bastian AJ. Cerebellum and the deciphering of motor coding. Cerebellum 2007; 6:3-6.
42. Ito M. Cerebellar circuitry as a neuronal machine. Prog Neurobiol 2006; 78: 272-303.
43. Maschke M, Gomez CM, Ebner TJ, Konczak J. Hereditary cerebellar ataxia progressively impairs force adaptation during goal-directed arm movements. J Neurophysiol 2004; 91:230-238.
44. Pasalar S, Roitman AV, Durfee WK, Ebner TJ. Force field effects on cerebellar Purkinje cell discharge with implications for internal models. Nat Neurosci 2006; 9:1404-1411.